Your browser doesn't support javascript.
loading
Costos directos del tratamiento de pacientes con artritis reumatoide en Medellín, Colombia / Direct treatment-cost of patients with rheumatoid arthritis in Medellín, Colombia
Montoya, Nora; Gómez, Liliana; Vélez, Mauricio; Rosselli, Diego.
Affiliation
  • Montoya, Nora; Medicarte. Medellín. CO
  • Gómez, Liliana; Medicarte. Medellín. CO
  • Vélez, Mauricio; Medicarte. Medellín. CO
  • Rosselli, Diego; Universidad Javeriana. Facultad de Medicina. Departamento de Epidemiología Clínica y Bioestadística. Bogotá. CO
Rev. colomb. reumatol ; 18(1): 26-33, ene.-mar. 2011. ilus, tab
Article in Es | LILACS | ID: lil-636847
Responsible library: CO356.9
RESUMEN

Objetivo:

analizar variables clínicas y costos directos de una muestra de pacientes con artritis reumatoide atendidos en un centro de gestión farmacoterapéutica avanzada en Medellín, Colombia.

Métodos:

revisamos 408 historias clínicas del período 2007-2009 recogiendo información clínica y costos directos para el asegurador.

Resultados:

337 mujeres (82,6%), edad promedio 49,8 años (rango 4-91). Costo promedio mes $1,31 millones en 2007, $1,71 millones en 2008 y $1,99 millones en 2009; 87,9% del costo está representado por medicamentos.

Conclusiones:

los costos de tratamiento van en aumento, los medicamentos representan una proporción importante del costo total.
ABSTRACT

Objective:

to analyze clinical variables and direct costs of a sample of patients with rheumatoid arthritis from a specialized pharmacotherapeutic management center in Medellin, Colombia.

Methods:

we reviewed 408 clinical files of the period 2007-2009 collecting clinical information and direct costs to a local private health insurer.

Results:

337 women (82.6%), average age 49.8 (range 4-91). Average monthly cost increased from Col$1.31 million (around US$650) in 2007, to Col$1.71 million (~US$850) in 2008, and Col$1.99 million (~US$1000) in 2009; 87.9% of this cost represented by pharmaceuticals.

Conclusions:

costs of treatment are increasing, pharmaceuticals represent an important proportion of total cost.
Subject(s)
Key words
Full text: 1 Index: LILACS Main subject: Patients / Arthritis, Rheumatoid / Health Care Costs / Colombia Type of study: Health_economic_evaluation Limits: Adult / Aged / Aged80 / Humans Country/Region as subject: America do sul / Colombia Language: Es Journal: Rev. colomb. reumatol Journal subject: REUMATOLOGIA Year: 2011 Type: Article
Full text: 1 Index: LILACS Main subject: Patients / Arthritis, Rheumatoid / Health Care Costs / Colombia Type of study: Health_economic_evaluation Limits: Adult / Aged / Aged80 / Humans Country/Region as subject: America do sul / Colombia Language: Es Journal: Rev. colomb. reumatol Journal subject: REUMATOLOGIA Year: 2011 Type: Article